2m 2m 2m 2m 2m 2m 2m
CASTLE BIOSCI (CSTL)
NASDAQ
$22.11+$0.73 (+3.43%)
Price as of Jun 23, 2026 7:10 PM EDT- $643.0MMarket Cap
- 11.59%1-Year Change
- Diagnostics & ResearchIndustry
CASTLE BIOSCI (CSTL)
$22.11+$0.73 (+3.43%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 344.2M +3.66% | 332.1M +51.09% | 219.8M +60.38% | 137.0M +45.65% | |
Cost of Revenue | 71.0M +17.98% | 60.2M +33.84% | 45.0M +40.53% | 32.0M +102.31% | |
Gross Profit | 273.2M +0.49% | 271.9M +55.52% | 174.8M +66.43% | 105.0M +34.20% | |
Sales and Marketing Expense | 229.3M +14.63% | 200.0M +11.04% | 180.2M +25.98% | 143.0M +64.87% | |
Research and Development Expense | -51.9M -0.37% | -52.0M -2.94% | -53.6M +19.41% | -44.9M +51.46% | |
Depreciation and Amortization Expense | 40.8M +154.87% | 16.0M +29.74% | 12.3M +16.95% | 10.5M +209.45% | |
Total Operating Expenses | 229.3M +14.63% | 200.0M +11.04% | 180.2M +25.98% | 143.0M +803.82% | |
Operating Profit | -42.8M -593.77% | 8.7M +112.75% | -68.0M -6.70% | -72.9M +81.78% | |
Interest Income | 11.8M -8.86% | 12.9M N/A | N/A N/A | 4.0M +5,735.29% | |
Interest Expense | N/A N/A | N/A N/A | -11,000 -35.29% | -17,000 +1,600.00% | |
Interest Income and Expense and Net | 11.8M -8.86% | 12.9M +117,518.18% | -11,000 -100.28% | 4.0M +5,797.01% | |
Total Nonoperating Income and Expense | 144,000 N/A | N/A N/A | 11,000 -35.29% | 17,000 +1,600.00% | |
Income before Taxes | -29.5M -236.87% | 21.6M +137.59% | -57.4M -16.75% | -68.9M +72.21% | |
Income Taxes | -5.4M -261.37% | 3.3M +3,186.14% | 101,000 +105.72% | -1.8M -79.75% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -24.2M -232.41% | 18.2M +131.75% | -57.5M -14.41% | -67.1M +114.55% | |
Net Income from Continuing Operations Applicable to Common | -24.2M -232.41% | 18.2M +131.75% | -57.5M -14.41% | -67.1M +114.55% | |
Basic EPS and Net Income | -0.83 -225.76% | 0.66 +130.84% | -2.14 -17.05% | -2.58 +108.06% | |
Diluted EPS and Net Income | -0.83 -233.87% | 0.62 +128.97% | -2.14 -17.05% | -2.58 +108.06% | |
Basic Weighted Average Shares | 29.0M +4.36% | 27.8M +3.63% | 26.8M +2.87% | 26.1M +3.65% | |
Diluted Weighted Average Shares | 29.0M -0.92% | 29.3M +9.15% | 26.8M +2.87% | 26.1M +3.65% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 116.7M -2.49% | 119.7M +21.11% | 98.8M -19.61% | 122.9M -62.70% | |
Short-Term Investments | 182.8M +5.39% | 173.4M +20.22% | 144.3M +6.32% | 135.7M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 299.5M +2.17% | 293.1M +20.58% | 243.1M -6.00% | 258.6M -21.54% | |
Total Current Assets | 361.1M +0.26% | 360.2M +21.82% | 295.6M +1.15% | 292.3M -17.37% | |
Accumulated Depreciation | 18.3M +42.58% | 12.8M +58.22% | 8.1M +3.35% | 7.8M +157.99% | |
Property and Plant and Equipment and Net | 97.4M +90.61% | 51.1M +101.01% | 25.4M +77.67% | 14.3M +50.67% | |
Total Long-Term Assets | 3.8M +206.92% | 1.2M -14.72% | 1.4M +29.73% | 1.1M -35.28% | |
Total Assets | 578.6M +8.91% | 531.2M +17.18% | 453.3M +1.34% | 447.3M -3.30% | |
Income Taxes Payable | 2.3M +45.30% | 1.6M +680.10% | 206,000 -51.87% | 428,000 -32.60% | |
Total Short-Term Debt | 417,000 +50.00% | 278,000 N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 68.7M +39.04% | 49.4M +3.62% | 47.7M +31.94% | 36.1M +45.17% | |
Total Long-Term Debt | 9.6M -1.08% | 9.7M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 39.5M +44.77% | 27.3M +109,116.00% | 25,000 -72.22% | 90,000 -27.42% | |
Total Liabilities | 107.7M +42.82% | 75.4M +21.47% | 62.1M +28.83% | 48.2M -5.22% | |
Retained Earnings | -224.3M +12.07% | -200.1M -8.36% | -218.4M +35.71% | -160.9M +71.60% | |
Total Stockholders Equity | 470.9M +3.30% | 455.8M +16.50% | 391.3M -1.97% | 399.1M -3.06% | |
Total Shares Outstanding | 29.7M +4.22% | 28.5M +3.91% | 27.4M +3.23% | 26.6M +4.63% | |
Cash Flow | |||||
Cash from Operating Activities | 64.3M -0.80% | 64.9M +1,252.97% | -5.6M -86.49% | -41.7M +119.43% | |
Capital Expenditures | 36.0M +27.17% | 28.3M +107.96% | 13.6M +141.85% | 5.6M +61.70% | |
Cash from Investing Activities | -60.4M +20.40% | -50.1M +209.81% | -16.2M -90.28% | -166.5M +149.85% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -7.0M -213.37% | 6.1M +367.15% | -2.3M -251.68% | 1.5M -72.05% | |
Financials Ratio | |||||
Gross Margin | 79.37% -3.06% | 81.87% +2.94% | 79.53% +3.77% | 76.64% -7.86% | |
Operating Margin | -12.44% -576.33% | 2.61% +108.44% | -30.93% -41.82% | -53.16% +24.80% | |
Return on Assets | -4.35% -217.47% | 3.71% +129.04% | -12.76% -13.53% | -14.76% +112.67% | |
Return on Equity | -5.21% -221.03% | 4.31% +129.62% | -14.54% -12.19% | -16.56% +118.93% | |
Revenue Growth | 3.66% -92.83% | 51.09% -15.40% | 60.38% +32.26% | 45.65% -9.01% | |
Current Ratio | 5.26 -27.89% | 7.29 +17.57% | 6.20 -23.34% | 8.09 -43.08% | |
Cash Ratio | 1.70 -29.87% | 2.42 +16.88% | 2.07 -39.07% | 3.40 -74.31% | |
Debt-to-Equity Ratio | 0.02 -2.73% | 0.02 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.02 -7.94% | 0.02 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow